^
Association details:
Biomarker:No biomarker
Cancer:Ovarian Cancer
Drug:sorafenib (Multi-tyrosine kinase inhibitor, pan-RAF inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Ovarian cancer: Other recommended regimens…Sorafenib/topotecan